https://www.selleckchem.com/Androgen-Receptor.html
ening will decrease the mortality of patients. To investigate the association between KRAS/NRAS/BRAF mutations and metabolic parameters of pretreatment F-FDG PET/CT in colorectal cancer (CRC). A total of 85 patients with CRC were included in the study. PET/CT was performed in all the patients before surgery. The histopathological examination and analysis of the gene mutational status of the primary tumor were conducted. The associations among clinical features, PET metabolic parameters, and the gene mutational status were investigated.
Like
Comment
Share
